Cargando…
SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer
BACKGROUND: SLC25A22, a member of mitochondrial carrier system (MCS) family encoding a mitochondrial glutamate transporter, has been reported to have vital roles in promoting proliferation and migration in cancer. Gallbladder cancer (GBC) is the most common biliary tract malignancy and has a poor pr...
Autores principales: | Du, Pengcheng, Liang, Haibin, Fu, Xiaowei, Wu, Peng, Wang, Chao, Chen, Haimin, Zheng, Bingbing, Zhang, Jun, Hu, Shuanghui, Zeng, Rengui, Liang, Bo, Fang, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376740/ https://www.ncbi.nlm.nih.gov/pubmed/30814911 http://dx.doi.org/10.1186/s12935-019-0746-9 |
Ejemplares similares
-
miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma
por: Bao, Run-Fa, et al.
Publicado: (2016) -
Loss of PR55α promotes proliferation and metastasis by activating MAPK/AKT signaling in hepatocellular carcinoma
por: Zhao, JiangSheng, et al.
Publicado: (2021) -
CLDN2 inhibits the metastasis of osteosarcoma cells via down-regulating the afadin/ERK signaling pathway
por: Zhang, Xiaowei, et al.
Publicado: (2018) -
SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the PTEN Signaling Pathway
por: Chen, Ming-Wei, et al.
Publicado: (2018) -
PICALM exerts a role in promoting CRC progression through ERK/MAPK signaling pathway
por: Zhang, Xitao, et al.
Publicado: (2022)